These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21448747)

  • 1. A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.
    Avanti C; Amorij JP; Setyaningsih D; Hawe A; Jiskoot W; Visser J; Kedrov A; Driessen AJ; Hinrichs WL; Frijlink HW
    AAPS J; 2011 Jun; 13(2):284-90. PubMed ID: 21448747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers.
    Jakaria SM; Budil DE; Murtagh J
    Pharm Res; 2023 Oct; 40(10):2469-2478. PubMed ID: 37697173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.
    Avanti C; Permentier HP; Dam Av; Poole R; Jiskoot W; Frijlink HW; Hinrichs WL
    Mol Pharm; 2012 Mar; 9(3):554-62. PubMed ID: 22257021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The formation of oxytocin dimers is suppressed by the zinc-aspartate-oxytocin complex.
    Avanti C; Hinrichs WLJ; Casini A; Eissens AC; Van Dam A; Kedrov A; Driessen AJM; Frijlink HW; Permentier HP
    J Pharm Sci; 2013 Jun; 102(6):1734-1741. PubMed ID: 23589380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspartate buffer and divalent metal ions affect oxytocin in aqueous solution and protect it from degradation.
    Avanti C; Oktaviani NA; Hinrichs WL; Frijlink HW; Mulder FA
    Int J Pharm; 2013 Feb; 444(1-2):139-45. PubMed ID: 23376504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions.
    Jakaria SM; Budil DE; Murtagh J
    Pharm Res; 2023 Aug; 40(8):2027-2037. PubMed ID: 37118348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-indicating HPLC method for the determination of the stability of oxytocin parenteral solutions prepared in polyolefin bags.
    Kaushal G; Sayre BE; Prettyman T
    Drug Discov Ther; 2012 Feb; 6(1):49-54. PubMed ID: 22460429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.
    Poole RA; Kasper PT; Jiskoot W
    J Pharm Sci; 2011 Jul; 100(7):3018-22. PubMed ID: 21547912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of minodronic acid in aqueous solution for parenteral formulation.
    Nakamura K; Tanaka T; Saito K; Yokohama S; Sonobe T
    Int J Pharm; 2001 Jul; 222(1):91-9. PubMed ID: 11404035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions.
    Ghasemisarabbadieh M; Gizurarson S; Sveinbjornsson BR
    ACS Omega; 2021 Mar; 6(8):5805-5811. PubMed ID: 33681619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive density functional theory study on the mechanism of activation of the nonapeptide hormone oxytocin by metal ions.
    Xu X; Yu W; Huang Z; Lin Z
    J Phys Chem B; 2010 Jan; 114(3):1417-23. PubMed ID: 20050588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of trehalose, antioxidants, and acetate buffer concentration on oxytocin stability.
    Ghasemisarabbadieh M; Gizurarson S; Sveinbjörnsson BR
    J Pept Sci; 2021 Jul; 27(7):e3324. PubMed ID: 33768618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cefsulodin in aqueous buffered solutions and some intravenous admixtures.
    Das Gupta V; Stewart KR
    J Clin Hosp Pharm; 1984 Mar; 9(1):21-7. PubMed ID: 6715559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of ionisable compounds on high-performance liquid chromatography. XV. Estimation of the pH variation of aqueous buffers with the change of the acetonitrile fraction of the mobile phase.
    Subirats X; Bosch E; Rosés M
    J Chromatogr A; 2004 Dec; 1059(1-2):33-42. PubMed ID: 15628122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
    Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
    Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures.
    Das Gupta V; Stewart KR
    J Clin Hosp Pharm; 1986 Feb; 11(1):47-54. PubMed ID: 3958213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-dependent effect of magnesium sulfate on the stability of penicillin G potassium solution.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1985 Mar; 42(3):598-602. PubMed ID: 3985024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.